Tīmeklis2024. gada 15. febr. · DALLAS, Feb. 15, 2024 /PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a Dallas-based clinical stage biopharmaceutical company using its proprietary artificial intelligence ("A.I.") platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that it is expanding … TīmeklisThe Dallas-based biopharmaceutical company expects to begin testing the drug candidate in a “first in human” trial in mid-2024. The drug was developed using the publicly traded company’s AI/ML drug development platform. Lantern, in collaboration with the National Cancer Institute, recently published insights on how AI can be used …
LTRN - Lantern Pharma Inc. Stock Price and Quote - FINVIZ.com
Tīmeklis2024. gada 28. marts · DALLAS--(BUSINESS WIRE)-- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company using its proprietary RADR ® artificial intelligence ("AI") and machine learning (“ML”) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced … TīmeklisOrganization Profile. Lantern Pharma Inc. is a corporation in Dallas, Texas. The employer identification number (EIN) for Lantern Pharma Inc. is 463973463. EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply IRS Number. It is one of the corporates which submit 10-K filings with the SEC. does amazon prime have free books to read
Join Us - Lantern Pharma Inc.
TīmeklisDALLAS--(BUSINESS WIRE)-- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") … TīmeklisLantern Pharma, Inc. is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action. Lantern also … TīmeklisWe are an emerging, oncology-focused, clinical-stage pharmaceutical company at the intersection of artificial intelligence, genomics, and machine learning. We are … eyelash types